A novel anti-CD20, concabody, enhances immunotherapy efficacy by targeting MPZL1 and augmenting antibody-induced cell death.

Choi A-Y, Kim D H, Lee C, Ahn J-S, Yang D-H, Lee DH, Kim J Y

Front Oncol. 2026; 16:1748576. PMID: 42063704. Abstract